Skip to content

Opening book details…

About this Medicine article

Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program by Levy, Gallia G.; Asikanius, Elina; Kuebler, Peter; Benchikh El Fegoun, Soraya; Esbjerg, Sille; Seremetis, Stephanie is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Levy, Gallia G.; Asikanius, Elina; Kuebler, Peter; Benchikh El Fegoun, Soraya; Esbjerg, Sille; Seremetis, Stephanie
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 1538-7933)
Published
2019
Field
Medicine (Health Sciences)

More by Levy, Gallia G.; Asikanius, Elina; Kuebler, Peter; Benchikh El Fegoun, Soraya; Esbjerg, Sille; Seremetis, Stephanie

Browse all works by Levy, Gallia G.; Asikanius, Elina; Kuebler, Peter; Benchikh El Fegoun, Soraya; Esbjerg, Sille; Seremetis, Stephanie